Terms: = Brain cancer AND KMT2C, ENSG00000055609, MLL3, 58508
20 results:
1. Deciphering brain Metastasis Stem Cell Properties From Colorectal cancer Highlights Specific Stemness Signature and Shared Molecular Features.
Desette A; Guichet PO; Emambux S; Masliantsev K; Cortes U; Ndiaye B; Milin S; George S; Faigner M; Tisserand J; Gaillard A; Brot S; Wager M; Tougeron D; Karayan-Tapon L
Cell Mol Gastroenterol Hepatol; 2023; 16(5):757-782. PubMed ID: 37482243
[TBL] [Abstract] [Full Text] [Related]
2. Genomic Landscape of Normal and Breast cancer Tissues in a Hungarian Pilot Cohort.
Pipek O; Alpár D; Rusz O; Bödör C; Udvarnoki Z; Medgyes-Horváth A; Csabai I; Szállási Z; Madaras L; Kahán Z; Cserni G; Kővári B; Kulka J; Tőkés AM
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239898
[TBL] [Abstract] [Full Text] [Related]
3. Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes.
Ren L; Hua L; Deng J; Cheng H; Wang D; Chen J; Xie Q; Wakimoto H; Gong Y
Neurosurgery; 2023 Apr; 92(4):745-755. PubMed ID: 36512828
[TBL] [Abstract] [Full Text] [Related]
4. KMT2A-D pathogenicity, prevalence, and variation according to a population database.
Larson JK; Hunter-Schlichting DN; Crowgey EL; Mills LJ; Druley TE; Marcotte EL
Cancer Med; 2023 Mar; 12(6):7234-7245. PubMed ID: 36479909
[TBL] [Abstract] [Full Text] [Related]
5. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing.
Yim J; Koh J; Kim S; Song SG; Bae JM; Yun H; Sung JY; Kim TM; Park SH; Jeon YK
Am J Surg Pathol; 2022 Apr; 46(4):486-497. PubMed ID: 34980830
[TBL] [Abstract] [Full Text] [Related]
7. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive Bioinformatics Analysis of Key Methyltransferases and Demethylases for Histone Lysines in Hepatocellular Carcinoma.
Zheng Y; Tang L; Chen G; Liu Z
Technol Cancer Res Treat; 2020; 19():1533033820983284. PubMed ID: 33355042
[TBL] [Abstract] [Full Text] [Related]
9. Clinical and mutational profiles of adult medulloblastoma groups.
Wong GC; Li KK; Wang WW; Liu AP; Huang QJ; Chan AK; Poon MF; Chung NY; Wong QH; Chen H; Chan DTM; Liu XZ; Mao Y; Zhang ZY; Shi ZF; Ng HK
Acta Neuropathol Commun; 2020 Nov; 8(1):191. PubMed ID: 33172502
[TBL] [Abstract] [Full Text] [Related]
10. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
11. Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas.
Menyhárt O; Győrffy B
Ann Clin Transl Neurol; 2019 May; 6(5):990-1005. PubMed ID: 31139698
[TBL] [Abstract] [Full Text] [Related]
12. EZH2-, CHD4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients.
Zhang L; Liu Y; Wang M; Wu Z; Li N; Zhang J; Yang C
J Mol Cell Biol; 2017 Dec; 9(6):477-488. PubMed ID: 29272522
[TBL] [Abstract] [Full Text] [Related]
13. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
[TBL] [Abstract] [Full Text] [Related]
14. AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma.
Chow RD; Guzman CD; Wang G; Schmidt F; Youngblood MW; Ye L; Errami Y; Dong MB; Martinez MA; Zhang S; Renauer P; Bilguvar K; Gunel M; Sharp PA; Zhang F; Platt RJ; Chen S
Nat Neurosci; 2017 Oct; 20(10):1329-1341. PubMed ID: 28805815
[TBL] [Abstract] [Full Text] [Related]
15. Genomic Profiling of a Large Set of Diverse Pediatric cancers Identifies Known and Novel Mutations across Tumor Spectra.
Chmielecki J; Bailey M; He J; Elvin J; Vergilio JA; Ramkissoon S; Suh J; Frampton GM; Sun JX; Morley S; Spritz D; Ali S; Gay L; Erlich RL; Ross JS; Buxhaku J; Davies H; Faso V; Germain A; Glanville B; Miller VA; Stephens PJ; Janeway KA; Maris JM; Meshinchi S; Pugh TJ; Shern JF; Lipson D
Cancer Res; 2017 Jan; 77(2):509-519. PubMed ID: 28069802
[TBL] [Abstract] [Full Text] [Related]
16. Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing.
Patil V; Pal J; Somasundaram K
Oncotarget; 2015 Dec; 6(41):43452-71. PubMed ID: 26496030
[TBL] [Abstract] [Full Text] [Related]
17. Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors.
Bien-Willner GA; Mitra RD
Acta Neuropathol Commun; 2014 Jul; 2():74. PubMed ID: 25030029
[TBL] [Abstract] [Full Text] [Related]
18. Altered expression of MLL methyltransferase family genes in breast cancer.
Rabello Ddo A; de Moura CA; de Andrade RV; Motoyama AB; Silva FP
Int J Oncol; 2013 Aug; 43(2):653-60. PubMed ID: 23754336
[TBL] [Abstract] [Full Text] [Related]
19. The genetic landscape of the childhood cancer medulloblastoma.
Parsons DW; Li M; Zhang X; Jones S; Leary RJ; Lin JC; Boca SM; Carter H; Samayoa J; Bettegowda C; Gallia GL; Jallo GI; Binder ZA; Nikolsky Y; Hartigan J; Smith DR; Gerhard DS; Fults DW; VandenBerg S; Berger MS; Marie SK; Shinjo SM; Clara C; Phillips PC; Minturn JE; Biegel JA; Judkins AR; Resnick AC; Storm PB; Curran T; He Y; Rasheed BA; Friedman HS; Keir ST; McLendon R; Northcott PA; Taylor MD; Burger PC; Riggins GJ; Karchin R; Parmigiani G; Bigner DD; Yan H; Papadopoulos N; Vogelstein B; Kinzler KW; Velculescu VE
Science; 2011 Jan; 331(6016):435-9. PubMed ID: 21163964
[TBL] [Abstract] [Full Text] [Related]
20. Identification of frequently mutated genes with relevance to nonsense mediated mRNA decay in the high microsatellite instability cancers.
Shin N; You KT; Lee H; Kim WK; Song M; Choi HJ; Rhee H; Nam SW; Kim H
Int J Cancer; 2011 Jun; 128(12):2872-80. PubMed ID: 20824714
[TBL] [Abstract] [Full Text] [Related]
